Slagle Financial, LLC Bristol Myers Squibb CO Transaction History
Slagle Financial, LLC
- $225 Billion
- Q3 2024
A detailed history of Slagle Financial, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Slagle Financial, LLC holds 48,577 shares of BMY stock, worth $2.69 Million. This represents 1.12% of its overall portfolio holdings.
Number of Shares
48,577
Previous 44,642
8.81%
Holding current value
$2.69 Million
Previous $1.85 Billion
35.57%
% of portfolio
1.12%
Previous 0.95%
Shares
6 transactions
Others Institutions Holding BMY
# of Institutions
2,453Shares Held
1.5BCall Options Held
29.6MPut Options Held
32.1M-
Vanguard Group Inc Valley Forge, PA187MShares$10.3 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.8 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$5.07 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$4.14 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.27 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $118B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...